Skip to main content
logo
NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0640
-0.0010 (-1.54%)
Aug 26, 2026, 1:01 PM AEST

ASX:NSB Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.630.63-2.214.95-
Revenue Growth
97.98%---55.34%--
Gross Profit
0.490.4902.194.91-0.07
Operating Income
-4.48-4.48-2.010.16-1.17-10.5
Net Income
-4.69-4.69-1.850.32-1.07-10.44
Earnings Per Share
-0.01-0.01-0.010.00-0.01-0.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
4.634.637.274.954.917.22
Total Debt
0.090.09----
Net Cash (Debt)
4.544.547.274.954.917.22
Net Cash Growth
-28.54%-37.48%46.66%0.86%-31.93%-49.05%
Net Cash Per Share
0.010.010.050.030.030.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-2.78-2.78-0.940.04-2.3-6.94
Capital Expenditures
----0--0
Free Cash Flow
-2.78-2.78-0.940.04-2.3-6.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
77.06%77.06%-98.90%99.07%-
Operating Margin
-711.56%-711.56%-7.02%-23.65%-
Pretax Margin
-745.66%-745.66%-14.66%-21.58%-
Profit Margin
-745.66%-745.66%-14.66%-21.57%-
FCF Margin
-441.39%-441.39%-1.92%-46.52%-

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
---17.84--
P/FCF Ratio
---136.31--
PS Ratio
39.6336.53-2.622.32-